2129 Predictive factor for toxicities and treatment termination in adjuvant capecitabine therapy for stage III colorectal cancer; based on the data of a randomized trial, JCOG0910. (September 2015) - Yoshida, Y.; Yamazaki, K.; Mizusawa, J.; Satoh, M.; Hinoi, T.; Tsuchida, A.; Otsuka, K.; Sato, T.; Watanabe, M.; Baba, H.; Kimura, H.; Idani, H.; et al.